SCHEMBL4769320

SCHEMBL4769320

COC(=O)c1ccc(SCc2ccc(Cl)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.66
MEN1 O00255 7/20 0.66
MAPT P10636 6/20 0.66
LMNA P02545 6/20 0.66
HPGD P15428 3/20 0.66
SMN1; SMN2 Q16637 8/20 0.61
RAB9A P51151 7/20 0.61
NPC1 O15118 5/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
ALDH1A1 P00352 5/20 0.58
NPSR1 Q6W5P4 2/20 0.57
DRD2 P14416 1/20 0.56
TBXA2R P21731 1/20 0.56
MAPK1 P28482 1/20 0.55
STAT3 P40763 1/20 0.55
HSD11B1 P28845 1/20 0.54
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7164014 0.85 KMT2A (0.56) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL3916950 0.84 RAB9A (0.61) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL31395362 0.84 KMT2A (0.54) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL694212 0.83 KMT2A (0.53) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL11700132 0.83 KMT2A (0.67) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL3919430 0.82 GSK3A (0.62) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL4551075 0.81 MEN1 (0.64) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL7411710 0.80 NPC1 (0.60) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL196916 0.80 CA1 (0.64) KMT2AMEN1MAPTLMNAHPGD
SCHEMBL7789813 0.78 CYP1A2 (0.59) MAPTLMNAHPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1907372-A1 SUBSTITUTED CYCLOHEXYL DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LTD. (GB) 2008-04-09 EP disclosed
WO-2007003965-A1 SUBSTITUTED CYCLOHEXYL DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2007-01-11 WO disclosed